VitaNova Life Sciences Corp. (VNOV) intrinsic value & 10-year financials
VitaNova Life Sciences Corp. (VNOV) has a Graham intrinsic value of $1.00 per share. At $3.60 on Oct 17, 2026, the stock trades 260% above that value. Over the last 9 fiscal years revenue grew 63.9% a year to $2.7M, with an average return on invested capital of 241.2%.
- Graham intrinsic value
- $1.00
- Share price (Oct 17, 2026)
- $3.60
- Price vs Graham value
- 260% above
- Market cap
- $90.0M
- Revenue (FY2025)
- $2.7M
- Revenue growth (9-yr CAGR)
- 63.9%
- ROIC (10-yr avg)
- 241.2%
- Free cash flow (FY2025)
- —
VNOV 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $2.7M | $850.7K | $0.03 | — | 45.4% | 57.6% |
| FY2024 | $570.7K | $140.9K | $0.01 | — | 36.0% | 28.3% |
| FY2023 | $38.0K | -$24.2K | $0.00 | — | -63.8% | 51.4% |
| FY2022 | $120.0K | $139.7K | $0.02 | — | -11.1% | 12.8% |
| FY2021 | $0 | -$52.1K | -$0.01 | — | — | 35.1% |
| FY2020 | $0 | -$72.3K | — | — | — | 83.7% |
| FY2019 | $0 | -$106.2K | — | — | — | 1776.0% |
| FY2018 | $83.9K | -$1.6K | — | — | -58.0% | -115.4% |
| FY2017 | $0 | -$7.2K | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
VitaNova Life Sciences Corp revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
VitaNova Life Sciences Corp has earned high returns on invested capital, averaging 21.4% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.
VitaNova Life Sciences Corp has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, VitaNova Life Sciences Corp is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $1.00 per share.